Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
hBVP |
Human brain vascular pericytes | Human | brain | unknown | adherent | mRNA | K2 Transfection System | application note | ![]() |
||||
hDF |
Human adult dermal fibroblasts | Human | skin | unknown | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
HECa10 |
Mouse endothelial cells of peripheral lymph nodes | Mouse | immune system | cell line | adherent | plasmid | CRISPR | K2 Transfection System | publication | P. Janus et al., Cell Death & Differentiation, 2020, 27: 2280–2292, doi.org/10.1038/s41418-020-0501-8 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | R. Roman et al., J.of Biotechnology, 2016, 239: 57-60, doi.org/10.1016/j.jbiotec.2016.10.005 | |||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/miRNA) | K2 Transfection System | publication | Z. Qian et al., Am. J. Physiol. Lung Cell Mol. Physiol., 2018, 315: L965–L976, doi:10.1152/ajplung.00224.2018 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | S.Y. Kim et al., J. of Cell Science, 2019, 132, jcs228940, doi:10.1242/jcs.228940 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | miRNA | cotransfection (plasmid/miRNA) | K2 Transfection System | publication | Z. Qian et al., Oncotarget, 2016, 7 (34):54998 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | D. C. Soler et al., Scientific Reports, 2019, 9:15263, doi.org/10.1038/s41598-019-51336 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | miRNA | cotransfection (plasmid/miRNA) | K2 Transfection System | publication | Z. Qian et al., Am. J. Physiol. Lung Cell Mol. Physiol., 2018, 315: L965–L976, doi:10.1152/ajplung.00224.2018 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | M. F. Fjelldal et al., Pharmacol. Res. Perspect., 2019, e00480, DOI: 10.1002/prp2.480 | Link | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | CRISPR | K2 Transfection System | publication | R. Roman et al., BMC Proceedings, 2020, 14 (Suppl 5): P-112 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | V. Morales-Garcia et al., FEBS Open Bio 10, 2020, 2541–2552, doi:10.1002/2211-5463.12987 | ||
HEK293 (s) |
Human embryonic kidney cell line (suspension) | ATCC CRL-1573 | Human | urinary system | cell line | suspension | plasmid | K2 Transfection System | application note | ![]() |
|||
HEKT Epac-S-H187 |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | A. Rodrıguez Gonzalez et al., The FEBS J., 2020, 288:229–243, doi:10.1111/febs.15344 | ||||
HEKT Epac-S-H187 |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | C. I. McCarthy et al., J. Gen. Physiol., 2020, 152, 5: e201912492, doi.org/10.1085/jgp.201912492 | Link | |||
HEKT Epac-S-H187 |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | E. Echeverría et al., Front. Pharmacol., 2020, 11: 113, doi: 10.3389/fphar.2020.00113 | Link | |||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | publication | E. Echeverria et al., Life Sciences, 2019, 239, 116872, doi.org/10.1016/j.lfs.2019.116872 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | peptide | K2 Transfection System | publication | L. Iarriccio et al., PLOS ONE, 2015, DOI:10.1371/journal.pone.0142980 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | C. D. Zappia et al., Scientific Reports, 2015, 5:17476, DOI: 10.1038/srep17476 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |